SPATA5-related disorder (NEDCAS) typically features earlier seizure onset, more severe microcephaly, and more frequent movement disorders [5], whereas SPATA5L1-associated disease more consistently presents with spastic–dystonic motor features and sensorineural hearing loss [1]. Here, AFG2B is linked to neurodevelopmental disorder with cerebellar atrophy and with or without seizures.